Revive Therapeutics has an EPS of $-0.02. In 2022, the company made an earnings per share (EPS) of $-0.06. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.02 | -66.67% |
2022 | -$0.06 | -25.00% |
2021 | -$0.08 | 60.00% |
2020 | -$0.05 | - |